ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATHA Athira Pharma Inc

2.54
-0.01 (-0.39%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Athira Pharma Inc NASDAQ:ATHA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -0.39% 2.54 1.93 3.62 2.56 2.47 2.52 145,877 05:00:06

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

29/11/2023 12:00pm

GlobeNewswire Inc.


Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Athira Pharma Charts.

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the Sidoti December Small Cap Conference, taking place virtually from December 6-7, 2023. Details are as follows:

Sidoti December Small Cap ConferenceFormat: Company PresentationDate and Time: Wednesday, December 6, 2023, from 12:15 pm - 12:45 pm EST Location: Virtual

A live webcast of the presentation can be accessed from the Investors section of the Athira website at https://investors.athira.com/news-and-events/events-and-presentations-investor. An archived replay will be available for at least 30 days following the event.

Athira Pharma will also host virtual one-on-one meetings with investors on Wednesday, December 6 and Thursday, December 7. To register for the conference and schedule a one-on-one meeting, please visithttps://sidoti.com/events.

About Athira Pharma, Inc.Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to alter the course of neurological disease by advancing its pipeline of therapeutic candidates targeting the HGF neurotrophic system for Alzheimer’s and Parkinson’s disease, Dementia with Lewy bodies, and amyotrophic lateral sclerosis. For more information, visit www.athira.com. You can also follow Athira on Facebook, LinkedIn and @athirapharma on X, formerly known as Twitter, and Instagram.

Investor & Media Contact:

Julie RathbunAthira PharmaJulie.rathbun@athira.com206-769-9219

1 Year Athira Pharma Chart

1 Year Athira Pharma Chart

1 Month Athira Pharma Chart

1 Month Athira Pharma Chart

Your Recent History

Delayed Upgrade Clock